EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access

Use of Continuous Glucose Monitors in Publicly Insured Youth With Type 2 Diabetes: A 12-month Pilot and Feasibility Study

Sejal Shah iD, Molly L Tanenbaum iD, Alondra Loyola iD, Nathan Grant L Sala iD, Himani Darji iD, Sarah Hanes iD, Franziska K Bishop iD, Korey K Hood iD, David M Maahs iD

Journal of Diabetes Science and Technology · 2026-11 · 20 (6) · 1807-1816

DOI: 10.1177/19322968251368366 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Journal of Diabetes Science and Technology, online erschienen am 20.09.2025. Verfasst von Sejal Shah und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Pediatric Endocrinology, Stanford University School of Medicine, Stanford, CA, USA. Hauptthemen laut MEDLINE: Blood Glucose, Blood Glucose Self-Monitoring, Continuous Glucose Monitoring, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, Stanford Diabetes Research Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Type 2 diabetes (T2D) disproportionately affects youth with public insurance of minority and lower socioeconomic status backgrounds. We aimed to determine feasibility of CGM use in this understudied population.

Methods

We enrolled youth 75% wear-time as goal) from downloaded report prior to clinic visit. Exploratory outcomes included: 14-day CGM wear time in range (TIR: % time spent between 70 and 180 mg/dl), HbA1c, and patient-reported outcomes (PROs) collected from youth and parents.

Results

We enrolled 30 youth (age 15.1 years [SD 2.48]; HbA1c 10.2%, range: 6.5%-15.5%), 46.7% female, 90% Hispanic. At baseline, 37% previously used CGM and 53% lacked glucometer data. CGM use was 50% at three months and 23% at 12 months. CGM wear time decreased by 6.4 days per two weeks by 12 months. Mean HbA1c was 9.8% at 12 months and median TIR decreased from 71% to 42%. Parents and youth had moderate-to-positive attitudes about diabetes technology. Youth endorsed fair levels of global health; and youth and parents endorsed fair general and diabetes-related health-related quality of life.

Conclusions

Strategies for sustained CGM use in youth with T2D may differ from adults with T2D or youth with type 1 diabetes. Additional studies are needed to evaluate facilitators and barriers of sustained CGM use to optimize CGM use in youth with T2D. Clinicaltrials.gov registration: NCT05074667.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood GlucoseBlood Glucose Self-MonitoringContinuous Glucose MonitoringDiabetes Mellitus, Type 2AdolescentFemaleHumansMaleYoung AdultFeasibility StudiesGlycated HemoglobinInsurance, HealthPatient Reported Outcome MeasuresPilot Projects

Stichwörter der Autor:innen

continuous glucose monitorpediatricspublic insurancetype 2 diabetes

Substanzen

Blood GlucoseGlycated Hemoglobinhemoglobin A1c protein, human

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Pediatric Endocrinology, Stanford University School of Medicine, Stanford, CA, USA.
  • Division of Endocrinology, Gerontology, & Metabolism, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Quantitative Sciences Unit, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Stanford Diabetes Research Center, Stanford, CA, USA.

ORCID-Profile: Sejal Shah, Molly L Tanenbaum, Alondra Loyola, Nathan Grant L Sala, Himani Darji, Sarah Hanes, Franziska K Bishop, Korey K Hood, David M Maahs

Förderung

  • NIDDK NIH HHS
  • NCATS NIH HHS
  • Stanford Diabetes Research Center
  • Stanford REDCap – Stanford Medicine Research Technology team
  • NIH funding source of Stanford’s Center for Clinical and Translational Education and Research award, under the Biostatistics, Epidemiology and Research Design…
  • Stanford Maternal and Child Health Research Institute

Zitieren

APA

Shah, S., Tanenbaum, M. L., Loyola, A., Sala, N. G. L., Darji, H., Hanes, S., Bishop, F. K., Hood, K. K., & Maahs, D. M. (2026). Use of Continuous Glucose Monitors in Publicly Insured Youth With Type 2 Diabetes: A 12-month Pilot and Feasibility Study. Journal of Diabetes Science and Technology, 20(6), 1807-1816. https://doi.org/10.1177/19322968251368366

Vancouver

Shah S, Tanenbaum ML, Loyola A, Sala NGL, Darji H, Hanes S, et al. Use of Continuous Glucose Monitors in Publicly Insured Youth With Type 2 Diabetes: A 12-month Pilot and Feasibility Study. Journal of Diabetes Science and Technology. 2026;20(6):1807-1816. doi:10.1177/19322968251368366

BibTeX
@article{Shah2026,
  author = {Shah, Sejal and Tanenbaum, Molly L and Loyola, Alondra and Sala, Nathan Grant L and Darji, Himani and Hanes, Sarah and Bishop, Franziska K and Hood, Korey K and Maahs, David M},
  title = {Use of Continuous Glucose Monitors in Publicly Insured Youth With Type 2 Diabetes: A 12-month Pilot and Feasibility Study},
  journal = {Journal of Diabetes Science and Technology},
  year = {2026},
  volume = {20},
  number = {6},
  pages = {1807--1816},
  doi = {10.1177/19322968251368366}
}
Kostenlos starten →